[Frailty and pharmacotherapy] [0.03%]
虚弱与药物治疗
Annette Eidam,Hanna M Seidling,Julia C Stingl et al.
Annette Eidam et al.
Older adults with frailty show an increased vulnerability to suffer negative health events, e.g., in the context of adverse drug reactions. Owing to the complex clinical needs of this population, older adults with frailty should receive a f...
Georgia Metzgeroth,Jan Hastka
Georgia Metzgeroth
Published Erratum
Innere Medizin (Heidelberg, Germany). 2025 Aug 29. DOI:10.1007/s00108-025-01941-1 2025
Magdalena Koehler,Teresa Charlotte Funk-Hilsdorf,Friedrich Koehler
Magdalena Koehler
As a digital care concept, telemedical care for patients with chronic heart failure has developed into an independent method in recent years. It complements the outpatient care provided by general practitioners (GPs) and specialists. Random...
[Semaglutide in the treatment of metabolic dysfunction-associated steatohepatitis (MASH)-a turning point?] [0.03%]
司美格鲁肽治疗与代谢紊乱相关的肝硬化(MASH)的疗效-一个转折点?
Münevver Demir,Sirka Nitschmann
Münevver Demir
Kai Schmidt-Ott,Michael P Manns
Kai Schmidt-Ott
Winfried V Kern,Sören G Gatermann
Winfried V Kern
Numerous new developments in antibacterial substances have been observed in recent years. Most of these are further developments of existing classes, especially beta-lactams, including beta-lactamase inhibitors. These included MRSA-active c...
M Cristina Polidori
M Cristina Polidori
Frailty is an established clinical syndrome that occurs more frequently with increasing age, but also often contributes to irreversible functional loss in younger adults. Its multidimensional, complex pathophysiology and phenotypic nature i...